RNTX

$1.42

Market ClosedAs of Mar 17, 8:00 PM UTC

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News